IDiyas

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 11319295 B1

PDFFull Text
Date of Patent:
May. 03, 2022

Filed:

Oct. 04, 2018

Substituted phenyloxetane and phenyltetrahydrofuran compounds as indoleamine 2,3-dioxygenase (ido) inhibitors

Applicants:

Merck Sharp & Dohme Corp., Rahway, NJ (US);

Catherine M. White, Newton Center, MA (US);

Meredeth Ann Mcgowan, Boston, MA (US);

Yongxin Han, Needham, MA (US);

Nunzio Sciammetta, Sudbury, MA (US);

Inventors:

Catherine M. White, Newton Center, MA (US);

Meredeth Ann McGowan, Boston, MA (US);

Yongxin Han, Needham, MA (US);

Nunzio Sciammetta, Sudbury, MA (US);

Assignee:

MERCK SHARP & DOHME CORP., Rahway, NJ (US);

Attorneys:

Yong Zhao

Catherine D. Fitch

Primary Examiner:

Taylor V Oh

Int. Cl.
CPC ...
C07D 305/08 (2006.01); A61P 37/00 (2006.01); A61P 25/28 (2006.01); A61P 31/12 (2006.01); A61P 25/24 (2006.01); A61P 27/12 (2006.01); A61P 35/00 (2006.01); C07D 307/22 (2006.01); C07D 307/24 (2006.01); C07D 405/04 (2006.01); A61K 45/06 (2006.01);
U.S. Cl.
CPC ...
C07D 305/08 (2013.01); A61P 25/24 (2018.01); A61P 25/28 (2018.01); A61P 27/12 (2018.01); A61P 31/12 (2018.01); A61P 35/00 (2018.01); A61P 37/00 (2018.01); C07D 307/22 (2013.01); C07D 307/24 (2013.01); C07D 405/04 (2013.01); A61K 45/06 (2013.01);
Abstract

Disclosed herein is a compound of formula (I), or a pharmaceutically acceptable salt thereof: (Formula (I)). Also disclosed herein are uses of a compound disclosed herein in the potential treatment or prevention of an IDO-associated disease or disorder. Also disclosed herein are compositions comprising a compound disclosed herein. Further disclosed herein are uses of a composition in the potential treatment or prevention of an IDO-associated disease or disorder.

Find Patent Forward Citations

Loading…